加载中
HKSEHealthcareDrug Manufacturers - Specialty & Generic
最新数据
HK$1.935
+HK$0.01 · +0.52%
Golden Throat Holdings Group Company Limited operates as an investment holding entity primarily engaged in the production and distribution of pharmaceutical goods, health-focused foods, and various other products within the People's Republic of China. Among its offerings are the widely recognized Golden Throat lozenges, an over-the-counter remedy designed to alleviate discomfort from sore and dry throats, as well as hoarseness often stemming from acute pharyngitis. The company further expands its Golden Throat lozenge line with products like Dule lozenges and their sugar-free counterparts, available in diverse flavors including orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn. Additionally, Golden Throat manufactures the Yinxingye tablet, formulated to enhance blood circulation, disperse blood stasis, and clear energy pathways. Its product portfolio also encompasses herbal vegetable beverages, crafted to provide vocal comfort and soothe irritated throats. Beyond its domestic market, the company extends its reach globally, exporting its range of products to countries and regions such as the United States, Canada, Russia, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and across Africa. Established in 1956, Golden Throat Holdings Group Company Limited maintains its corporate headquarters in Liuzhou, within the People's Republic of China.
最新数据
HK$1.935
+HK$0.01 · +0.52%
盘中时间采用HKT。市场数据可能有所延迟。
Golden Throat Holdings Group Company Limited operates as an investment holding entity primarily engaged in the production and distribution of pharmaceutical goods, health-focused foods, and various other products within the People's Republic of China. Among its offerings are the widely recognized Golden Throat lozenges, an over-the-counter remedy designed to alleviate discomfort from sore and dry throats, as well as hoarseness often stemming from acute pharyngitis. The company further expands its Golden Throat lozenge line with products like Dule lozenges and their sugar-free counterparts, available in diverse flavors including orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn. Additionally, Golden Throat manufactures the Yinxingye tablet, formulated to enhance blood circulation, disperse blood stasis, and clear energy pathways. Its product portfolio also encompasses herbal vegetable beverages, crafted to provide vocal comfort and soothe irritated throats. Beyond its domestic market, the company extends its reach globally, exporting its range of products to countries and regions such as the United States, Canada, Russia, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and across Africa. Established in 1956, Golden Throat Holdings Group Company Limited maintains its corporate headquarters in Liuzhou, within the People's Republic of China.
日内区间
当前HK$1.935
52周区间
当前HK$1.935
盘中时间采用HKT。市场数据可能有所延迟。
Golden Throat Holdings Group Company Limited operates as an investment holding entity primarily engaged in the production and distribution of pharmaceutical goods, health-focused foods, and various other products within the People's Republic of China. Among its offerings are the widely recognized Golden Throat lozenges, an over-the-counter remedy designed to alleviate discomfort from sore and dry throats, as well as hoarseness often stemming from acute pharyngitis. The company further expands its Golden Throat lozenge line with products like Dule lozenges and their sugar-free counterparts, available in diverse flavors including orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn. Additionally, Golden Throat manufactures the Yinxingye tablet, formulated to enhance blood circulation, disperse blood stasis, and clear energy pathways. Its product portfolio also encompasses herbal vegetable beverages, crafted to provide vocal comfort and soothe irritated throats. Beyond its domestic market, the company extends its reach globally, exporting its range of products to countries and regions such as the United States, Canada, Russia, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and across Africa. Established in 1956, Golden Throat Holdings Group Company Limited maintains its corporate headquarters in Liuzhou, within the People's Republic of China.
日内区间
当前HK$1.935
52周区间
当前HK$1.935
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（CNY） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 9.43亿 CNY | 11.85亿 CNY | 9.61亿 CNY | 9.92亿 CNY | 8.21亿 CNY |
| 销货成本 | 2.26亿 CNY | 2.91亿 CNY | 2.64亿 CNY | 2.71亿 CNY | 2.43亿 CNY |
| 毛利 | 7.17亿 CNY | 8.94亿 CNY | 6.98亿 CNY | 7.21亿 CNY | 5.78亿 CNY |
| 研究与开发 | 392.9万 CNY | 3241.8万 CNY | 1707.3万 CNY | 642万 CNY | 2228.5万 CNY |
| 销售、一般及管理费用 | 4.1亿 CNY | 4.73亿 CNY | 3.61亿 CNY | 3.58亿 CNY | 3.65亿 CNY |
| 营业费用 | 4.14亿 CNY | 5.05亿 CNY | 3.78亿 CNY | 3.64亿 CNY | 3.87亿 CNY |
| 利息收入 | 2264.6万 CNY | 2524.9万 CNY | 2412.6万 CNY | 1655.3万 CNY | 1534.6万 CNY |
| 利息支出 | 1438.4万 CNY | 1536.3万 CNY | 1069.9万 CNY | 1029.4万 CNY | 797.5万 CNY |
| 折旧和摊销 | 3034.3万 CNY | 3642.7万 CNY | 3903.3万 CNY | 3864.4万 CNY | 3697.5万 CNY |
| 营业利润 | 3.03亿 CNY | 3.89亿 CNY | 3.49亿 CNY | 3.57亿 CNY | 1.91亿 CNY |
| 净利润 | 2.51亿 CNY | 3.19亿 CNY | 2.5亿 CNY | 2.81亿 CNY | 1.88亿 CNY |
公司数据更新于 2026年10月6日。
近期已公布业绩
近期已公布业绩
报告持有此股票敞口的交易所交易基金。
Dimensional - Emerging Markets Core Equity 2 ETFDFEM
Dimensional World ex U.S. Core Equity 2 ETFDFAX
Dimensional Emerging Markets Sustainability Core 1 ETFDFSEAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
